Credo Technology stock slips after 3M patent pact as CRDO investors eye what comes next
Credo shares fell about 0.6% to $138.29 after announcing a patent license and mutual covenant deal with 3M; financial terms were not disclosed. A trust tied to Credo’s CTO sold 30,000 shares on Jan. 15 under a preset plan. Rosenblatt began coverage at Neutral with a $170 target, citing long-term risks.